BMRN vs STEX · P/E 40, rev $1.76B vs rev $146.0K
Biomarin Pharmaceutical Inc (BMRN) versus Streamex Corp (STEX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Streamex Corp (STEX) is a capital markets company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported STEX revenue for 2026-06-30 was $146.0K. Net income was -$61.2M. STEX currently screens at market cap $216.5M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. STEX currently screens at market cap $216.5M.
Not investment advice. Open the BMRN and STEX stock pages for the full models.
Not investment advice.